Keep away from or Use Alternate Drug. Coadministration of apalutamide, a robust CYP3A4 inducer, with medicine which have been CYP3A4 substrates may lead to lessen exposure to these remedies. Steer clear of or substitute A different drug for these remedies when feasible. Appraise for lack of therapeutic effect if medication should be coadministered.